Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), 53085-53086 [2021-20741]
Download as PDF
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aster Juan, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20817, 301–435–5000,
juana2@mail.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Immunity and Host Defense Study Section.
Date: October 28–29, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–435–
1506, jakesse@mail.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative and Clinical Endocrinology and
Reproduction Study Section.
Date: October 28–29, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Developmental Therapeutics Study
Section.
Date: October 28–29, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nicholas J. Donato, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040,
Bethesda, MD 20892, 301–827–4810,
nick.donato@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Neurodegeneration Study Section.
Date: October 28–29, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christine Jean DiDonato,
Ph.D., Scientific Review Officer, Center for
VerDate Sep<11>2014
16:50 Sep 23, 2021
Jkt 253001
53085
Dated: September 21, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1014J,
Bethesda, MD 20892, (301) 435–1042,
didonatocj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2021–20788 Filed 9–23–21; 8:45 am]
Dated: September 21, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
Notice of Meeting for the
Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
[FR Doc. 2021–20784 Filed 9–23–21; 8:45 am]
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: October 20, 2021.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Vanitha Sundaresa Raman,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20852, 301–761–7949,
vanitha.raman@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services.
ACTION: Notice.
The Secretary of Health and
Human Services announces a meeting of
the Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC).
The ISMICC is open to the public and
can be accessed via telephone or
webcast only, and not in person.
Agenda with call-in information and the
draft report to Congress will be posted
on SAMHSA’s website prior to the
meeting at: https://www.samhsa.gov/
about-us/advisory-councils/meetings.
The meeting will address feedback from
the ISMICC members regarding the final
report to Congress and include
information on federal efforts related to
serious mental illness (SMI) and serious
emotional disturbance (SED).
DATES: October 27, 2021, 1:00 p.m.–5:00
p.m. (EDT)/Open.
ADDRESSES: The meeting will be held
virtually and can be accessed via Zoom.
FOR FURTHER INFORMATION CONTACT:
Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers
Lane, 14E53C, Rockville, MD 20857;
telephone: 240–276–1279; email:
pamela.foote@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background and Authority
The ISMICC was established on
March 15, 2017, in accordance with
section 6031 of the 21st Century Cures
Act, and the Federal Advisory
Committee Act, 5 U.S.C. app., as
amended, to report to the Secretary,
Congress, and any other relevant federal
department or agency on advances in
SMI and SED, research related to the
prevention of, diagnosis of, intervention
in, and treatment and recovery of SMIs,
SEDs, and advances in access to services
E:\FR\FM\24SEN1.SGM
24SEN1
53086
Federal Register / Vol. 86, No. 183 / Friday, September 24, 2021 / Notices
and supports for adults with SMI or
children with SED. In addition, the
ISMICC will evaluate the effect federal
programs related to SMI and SED have
on public health, including public
health outcomes such as: (A) Rates of
suicide, suicide attempts, incidence and
prevalence of SMIs, SEDs, and
substance use disorders, overdose,
overdose deaths, emergency
hospitalizations, emergency room
boarding, preventable emergency room
visits, interaction with the criminal
justice system, homelessness, and
unemployment; (B) increased rates of
employment and enrollment in
educational and vocational programs;
(C) quality of mental and substance use
disorders treatment services; or (D) any
other criteria determined by the
Secretary. Finally, the ISMICC will
make specific recommendations for
actions that agencies can take to better
coordinate the administration of mental
health services for adults with SMI or
children with SED. Not later than one
(1) year after the date of enactment of
the 21st Century Cures Act, and five (5)
years after such date of enactment, the
ISMICC shall submit a report to
Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal
members listed below or their
designees, and non-federal public
members.
Federal Membership: Members
include, The Secretary of Health and
Human Services; The Assistant
Secretary for Mental Health and
Substance Use; The Attorney General;
The Secretary of the Department of
Veterans Affairs; The Secretary of the
Department of Defense; The Secretary of
the Department of Housing and Urban
Development; The Secretary of the
Department of Education; The Secretary
of the Department of Labor; The
Administrator of the Centers for
Medicare and Medicaid Services; and
The Commissioner of the Social
Security Administration.
Non-federal Membership: Members
include, 15 non-federal public members
appointed by the Secretary, representing
psychologists, psychiatrists, social
workers, peer support specialists, and
other providers, patients, family of
patients, law enforcement, the judiciary,
and leading research, advocacy, or
service organizations.
The ISMICC is required to meet at
least twice per year.
To attend virtually, submit written or
brief oral comments, or request special
accommodation for persons with
disabilities, contact Pamela Foote.
VerDate Sep<11>2014
16:50 Sep 23, 2021
Jkt 253001
Individuals can also register on-line at:
https://snacregister.samhsa.gov/Meeting
List.aspx.
The public comment section will be
scheduled at the conclusion of the
meeting. Individuals interested in
submitting a comment, must notify
Pamela Foote on or before October 20,
2021 via email to: Pamela.Foote@
samhsa.hhs.gov.
Up to three minutes will be allotted
for each approved public comment as
time permits. Written comments
received in advance of the meeting will
be considered for inclusion in the
official record of the meeting.
Substantive meeting information and
a roster of Committee members is
available at the Committee’s website:
https://www.samhsa.gov/about-us/
advisory-councils/meetings.
Dated: September 20, 2021.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2021–20741 Filed 9–23–21; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket Number USCG–2021–0191]
Waterways Commerce Cutter
Acquisition Program; Preparation of a
Programmatic Environmental Impact
Statement
Coast Guard, DHS.
Notice of Availability of a Draft
Programmatic Environmental Impact
Statement; request for comments.
AGENCY:
ACTION:
The United States Coast
Guard (Coast Guard), as the lead agency,
announces the availability of the Draft
Programmatic Environmental Impact
Statement (PEIS) for the Waterways
Commerce Cutter (WCC) Program’s
acquisition and operation of a planned
30 WCCs. This PEIS is being prepared
in compliance with the National
Environmental Policy Act (NEPA; and
the regulations implemented by the
Council on Environmental Quality
(CEQ). The Coast Guard has determined
that a PEIS is the most appropriate type
of NEPA document for this action
because of the scope and complexity of
the proposed acquisition and operation
of a planned 30 WCCs. This notice of
availability (NOA) announces the start
of the public review and comment
period on this PEIS. After the Coast
Guard addresses comments provided,
Coast Guard will publish a final PEIS.
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Comments and related material
must be post-marked or received by the
Coast Guard on or before November 8,
2021.
ADDRESSES:
Obtaining Documents: You may
access the Draft PEIS from the Coast
Guard Office of Environmental
Management web page at https://
www.dcms.uscg.mil/Our-Organization/
Assistant-Commandant-for-EngineeringLogistics-CG-4-/Program-Offices/
Environmental-Management/
Environmental-Planning-and-HistoricPreservation/.
Submitting Comments: You may
submit comments on the Draft PEIS by
one of the following methods:
• Via the Web: You may submit
comments identified by docket number
USCG–2021–0191 using the Federal
eRulemaking Portal at https://
www.regulations.gov. See the ‘‘Public
Scoping Process’’ portion of the
SUPPLEMENTARY INFORMATION section for
further instructions on submitting
comments.
• Via U.S. Mail: U.S. Coast Guard
Headquarters, ATTN: LCDR S. Krolman
(CG–9327), 2703 Martin Luther King Jr
Ave. SE, Stop 7800, Washington DC
20593. Please note that mailed
comments must be postmarked on or
before the comment deadline of 45 days
following publication of this notice to
be considered.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
FOR FURTHER INFORMATION CONTACT: For
information about this document, email
HQS-SMB-CGWaterwaysCommerceCutter@uscg.mil.
SUPPLEMENTARY INFORMATION: This NOA
briefly summarizes the proposed
project, including the purpose and need
and reasonable alternatives. As required
by NEPA and CEQ implementing
regulations (40 CFR 1500–1508,
specifically § 1502.3), a Federal agency
must prepare an Environmental Impact
Statement (EIS) if it is proposing a major
Federal action to analyze the
environmental consequences of
implementing each of the alternatives, if
carried forward for full review following
public scoping, by assessing the effects
of each alternative on the natural and
human environment. The Coast Guard
DATES:
E:\FR\FM\24SEN1.SGM
24SEN1
Agencies
[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Pages 53085-53086]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20741]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting for the Interdepartmental Serious Mental
Illness Coordinating Committee (ISMICC)
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Secretary of Health and Human Services announces a meeting
of the Interdepartmental Serious Mental Illness Coordinating Committee
(ISMICC).
The ISMICC is open to the public and can be accessed via telephone
or webcast only, and not in person. Agenda with call-in information and
the draft report to Congress will be posted on SAMHSA's website prior
to the meeting at: https://www.samhsa.gov/about-us/advisory-councils/meetings. The meeting will address feedback from the ISMICC members
regarding the final report to Congress and include information on
federal efforts related to serious mental illness (SMI) and serious
emotional disturbance (SED).
DATES: October 27, 2021, 1:00 p.m.-5:00 p.m. (EDT)/Open.
ADDRESSES: The meeting will be held virtually and can be accessed via
Zoom.
FOR FURTHER INFORMATION CONTACT: Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers Lane, 14E53C, Rockville, MD
20857; telephone: 240-276-1279; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background and Authority
The ISMICC was established on March 15, 2017, in accordance with
section 6031 of the 21st Century Cures Act, and the Federal Advisory
Committee Act, 5 U.S.C. app., as amended, to report to the Secretary,
Congress, and any other relevant federal department or agency on
advances in SMI and SED, research related to the prevention of,
diagnosis of, intervention in, and treatment and recovery of SMIs,
SEDs, and advances in access to services
[[Page 53086]]
and supports for adults with SMI or children with SED. In addition, the
ISMICC will evaluate the effect federal programs related to SMI and SED
have on public health, including public health outcomes such as: (A)
Rates of suicide, suicide attempts, incidence and prevalence of SMIs,
SEDs, and substance use disorders, overdose, overdose deaths, emergency
hospitalizations, emergency room boarding, preventable emergency room
visits, interaction with the criminal justice system, homelessness, and
unemployment; (B) increased rates of employment and enrollment in
educational and vocational programs; (C) quality of mental and
substance use disorders treatment services; or (D) any other criteria
determined by the Secretary. Finally, the ISMICC will make specific
recommendations for actions that agencies can take to better coordinate
the administration of mental health services for adults with SMI or
children with SED. Not later than one (1) year after the date of
enactment of the 21st Century Cures Act, and five (5) years after such
date of enactment, the ISMICC shall submit a report to Congress and any
other relevant federal department or agency.
II. Membership
This ISMICC consists of federal members listed below or their
designees, and non-federal public members.
Federal Membership: Members include, The Secretary of Health and
Human Services; The Assistant Secretary for Mental Health and Substance
Use; The Attorney General; The Secretary of the Department of Veterans
Affairs; The Secretary of the Department of Defense; The Secretary of
the Department of Housing and Urban Development; The Secretary of the
Department of Education; The Secretary of the Department of Labor; The
Administrator of the Centers for Medicare and Medicaid Services; and
The Commissioner of the Social Security Administration.
Non-federal Membership: Members include, 15 non-federal public
members appointed by the Secretary, representing psychologists,
psychiatrists, social workers, peer support specialists, and other
providers, patients, family of patients, law enforcement, the
judiciary, and leading research, advocacy, or service organizations.
The ISMICC is required to meet at least twice per year.
To attend virtually, submit written or brief oral comments, or
request special accommodation for persons with disabilities, contact
Pamela Foote. Individuals can also register on-line at: https://snacregister.samhsa.gov/MeetingList.aspx.
The public comment section will be scheduled at the conclusion of
the meeting. Individuals interested in submitting a comment, must
notify Pamela Foote on or before October 20, 2021 via email to:
[email protected]
Up to three minutes will be allotted for each approved public
comment as time permits. Written comments received in advance of the
meeting will be considered for inclusion in the official record of the
meeting.
Substantive meeting information and a roster of Committee members
is available at the Committee's website: https://www.samhsa.gov/about-us/advisory-councils/meetings.
Dated: September 20, 2021.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2021-20741 Filed 9-23-21; 8:45 am]
BILLING CODE 4162-20-P